Guttman-Yassky, Emma, Alan Irvine, Eric Simpson, Melinda Gooderham, Stephan Weidinger, Lynda Spelman, Jonathan Silverberg, Heidi Crane, Hany Elmaraghy, Louise DeLuca-Carter, Maria Lucia Buziqui Piruzeli, Chaoran Hu, Evangeline Pierce, Helena Agell, and Diamant Thaçi. 2025. “Long-Term Efficacy and Safety of Lebrikizumab Is Maintained in Patients With Moderate-to-Severe ​ Atopic Dermatitis: Results Up to 3 Years From ADjoin”. SKIN The Journal of Cutaneous Medicine 9 (1):s510. https://doi.org/10.25251/skin.9.supp.510.